Print

OncoGenex Pharmaceuticals Inc. Provides Clinical Development Program Overview and Reports Financial Results for Second Quarter 2013  
8/9/2013 6:20:08 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 8, 2013 /PRNewswire via COMTEX/ -- OncoGenex Pharmaceuticals, Inc. /quotes/zigman/111981/quotes/nls/ogxi OGXI +1.80% today provided an overview of clinical development activities for its two product candidates, custirsen and apatorsen (OGX-427), and announced second quarter 2013 financial results.

Hey, check out all the engineering jobs. Post your resume today!

//-->